Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Pulmonary Hypertension

  Free Subscription


1 Acta Paediatr
1 Am J Perinatol
2 Am J Respir Cell Mol Biol
1 Ann Am Thorac Soc
1 Arch Bronconeumol
1 Arthritis Res Ther
1 Br J Pharmacol
1 Cardiol Rev
1 Chest
1 Clin Appl Thromb Hemost
1 Clin Exp Hypertens
1 Dev Dyn
1 ESC Heart Fail
1 Exp Cell Res
1 Expert Rev Respir Med
1 Front Pediatr
1 Heart Lung
1 Heart Lung Circ
1 Hypertension
1 Immunobiology
1 J Am Heart Assoc
1 J Card Fail
1 J Cell Mol Med
1 J Perinatol
1 Kardiol Pol
1 Med Clin (Barc)
1 Neonatology
1 PLoS One
2 Pulm Circ
1 Rheumatology (Oxford)
2 Sci Rep
1 Sleep Breath
1 Ugeskr Laeger
1 Value Health Reg Issues
1 Vasc Health Risk Manag

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Paediatr

  1. JAYAKUMAR N, Keir A
    EBNEO commentary: Oral versus intravenous sildenafil for pulmonary hypertension in neonates.
    Acta Paediatr. 2023 Mar 6. doi: 10.1111/apa.16725.

    Am J Perinatol

  2. DUGGAL M, Moore SS, Simoneau J, Girard G, et al
    Pulmonary Hypertension and Necrotizing Enterocolitis in Neonates Treated with Diazoxide.
    Am J Perinatol. 2023 Mar 7. doi: 10.1055/s-0043-1764385.
    PubMed         Abstract available

    Am J Respir Cell Mol Biol

  3. SANTOS-RIBEIRO D, Lecocq M, de Beukelaer M, Verleden S, et al
    Disruption of GCN2 Pathway Aggravates Vascular and Parenchymal Remodeling during Pulmonary Fibrosis.
    Am J Respir Cell Mol Biol. 2023;68:326-338.
    PubMed         Abstract available

    Integrating the Integrated Stress Response.
    Am J Respir Cell Mol Biol. 2023;68:243-244.

    Ann Am Thorac Soc

  5. LI B, Gillmeyer KR, Molloy-Paolillo B, Vimalananda VG, et al
    Scoping Review of Pulmonary Telemedicine Consults: Current Knowledge and Research Gaps.
    Ann Am Thorac Soc. 2023;20:456-465.
    PubMed         Abstract available

    Arch Bronconeumol

  6. CRUZ-UTRILLA A, Escribano Subias MP, Tenorio Castano JA, Del Cerro Marin MJ, et al
    Digenic Inheritance in a Case of Pulmonary Arterial Hypertension Associated with Two Incidental Septal Defects and Multiple Thoracic Collaterals.
    Arch Bronconeumol. 2023;59:169-170.

    Arthritis Res Ther

  7. XANTHOULI P, Gordjani O, Benjamin N, Harutyunova S, et al
    Hypochromic red cells as a prognostic indicator of survival among patients with systemic sclerosis screened for pulmonary hypertension.
    Arthritis Res Ther. 2023;25:38.
    PubMed         Abstract available

    Br J Pharmacol

  8. ZHANG C, Zhang T, Xing Y, Lu W, et al
    Airway Delivery of Streptococcus Salivarius is Sufficient to Induce Experimental Pulmonary Hypertension in Rat.
    Br J Pharmacol. 2023 Mar 4. doi: 10.1111/bph.16064.
    PubMed         Abstract available

    Cardiol Rev

  9. LEE KI, Manuntag LJ, Kifayat A, Manuntag SE, et al
    Cardiovascular Manifestations of Systemic Sclerosis: An Overview of Pathophysiology, Screening Modalities, and Treatment Options.
    Cardiol Rev. 2023;31:22-27.
    PubMed         Abstract available


  10. KITHAS AC, Ramani GV, Cassady SJ
    A Rapidly Evacuated Pericardial Effusion in the Setting of Chronic Pulmonary Hypertension.
    Chest. 2023;163:e137-e139.

    Clin Appl Thromb Hemost

  11. MYLLYLAHTI L, Ropponen J, Lax M, Lassila R, et al
    Upregulation of Coagulation Factor VIII and Fibrinogen After Pulmonary Endarterectomy in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Clin Appl Thromb Hemost. 2023;29:10760296231158369.
    PubMed         Abstract available

    Clin Exp Hypertens

  12. ZHANG M, Zeng Q, Zhou S, Zhu G, et al
    Mendelian randomization study on causal association of IL-6 signaling with pulmonary arterial hypertension.
    Clin Exp Hypertens. 2023;45:2183963.
    PubMed         Abstract available

    Dev Dyn

  13. UPTON PD, Dunmore BJ, Li W, Morrell NW, et al
    An emerging class of new therapeutics targeting TGF, Activin, and BMP ligands in pulmonary arterial hypertension.
    Dev Dyn. 2023;252:327-342.
    PubMed         Abstract available

    ESC Heart Fail

  14. HUNGERFORD SL, Kearney K, Song N, Bart N, et al
    Prognostic role of pulmonary impedance estimation to predict right ventricular dysfunction in pulmonary hypertension.
    ESC Heart Fail. 2023 Mar 10. doi: 10.1002/ehf2.14180.
    PubMed         Abstract available

    Exp Cell Res

  15. KANG T, Liu L, Tan F, Zhang D, et al
    Inhibition of YTHDF1 prevents hypoxia-induced pulmonary artery smooth muscle cell proliferation by regulating Foxm1 translation in an m6A-dependent manner.
    Exp Cell Res. 2023;424:113505.
    PubMed         Abstract available

    Expert Rev Respir Med

  16. ESCRIBANO SUBIAS P, Aurtenetxe Perez A, Perez Olivares C, Gomez Climent L, et al
    Recent advances in the management of pulmonary arterial hypertension: lessons from the upfront combination of ambrisentan and tadalafil.
    Expert Rev Respir Med. 2021;15:493-504.
    PubMed         Abstract available

    Front Pediatr

  17. HWANG JK, Shin SH, Kim EK, Kim SH, et al
    Association of newer definitions of bronchopulmonary dysplasia with pulmonary hypertension and long-term outcomes.
    Front Pediatr. 2023;11:1108925.
    PubMed         Abstract available

    Heart Lung

  18. KINGREY JF, Zhou CY, Dalal B, Elwing JM, et al
    Expert provider survey of longitudinal assessment in patients with pulmonary arterial hypertension.
    Heart Lung. 2023;58:34-38.
    PubMed         Abstract available

    Heart Lung Circ

  19. CHANDRASEKARA S, Lau EM, Anderson J, Collins N, et al
    Acute Vasoreactivity Testing and Outcomes in Pulmonary Arterial Hypertension: A Call for Increased Testing.
    Heart Lung Circ. 2023;32:156-165.
    PubMed         Abstract available


  20. SHI Y, Liu J, Zhang R, Zhang M, et al
    Targeting Endothelial ENO1 (Enolase) -PI3K-Akt-mTOR Axis Alleviates Hypoxic Pulmonary Hypertension.
    Hypertension. 2023 Mar 8. doi: 10.1161/HYPERTENSIONAHA.122.19857.
    PubMed         Abstract available


  21. WU DD, Deng Y, Liao J, Xie SS, et al
    STING mediates SU5416/hypoxia-induced pulmonary arterial hypertension in rats by regulating macrophage NLRP3 inflammasome activation.
    Immunobiology. 2023;228:152345.
    PubMed         Abstract available

    J Am Heart Assoc

  22. LEMAY SE, Grobs Y, Boucherat O
    Right Ventricular Dysfunction in Pulmonary Hypertension: Is Resistin a Promising Target?
    J Am Heart Assoc. 2023 Mar 9:e8285. doi: 10.1161/JAHA.123.029503.

    J Card Fail

  23. LANGLAIS EL, Avram R
    Overcoming Diagnostic Delays in Pulmonary Hypertension with Deep Learning ECG Analysis.
    J Card Fail. 2023 Mar 4:S1071-9164(23)00063.

    J Cell Mol Med

  24. LIU Y, Tang BL, Lu ML, Wang HX, et al
    Astragaloside IV improves pulmonary arterial hypertension by increasing the expression of CCN1 and activating the ERK1/2 pathway.
    J Cell Mol Med. 2023;27:622-633.
    PubMed         Abstract available

    J Perinatol

  25. YURTTUTAN S, Gullu UU
    Neonatal AKI in late preterm infants with patent ductus arteriosus.
    J Perinatol. 2021;41:2383-2384.

    Kardiol Pol

  26. CRUZ-UTRILLA A, Garcia-Martin EP, Dominguez Perez L, Ruiz Curiel A, et al
    ECMO in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension as a bridge-to-therapy.
    Kardiol Pol. 2023 Mar 5. doi: 10.33963/KP.a2023.0055.

    Med Clin (Barc)

  27. MATUTE GUERRERO A, Abanses Moreno P, Villasmil Chaparro I
    Pulmonary thrombotic microangiopathy caused by neoplastic urothelial carcinoma cells.
    Med Clin (Barc). 2023;160:226-227.


  28. HORN-OUDSHOORN EJJ, Vermeulen MJ, Knol R, Te Pas AB, et al
    The Oxygen Saturation Index as Early Predictor of Outcomes in Congenital Diaphragmatic Hernia.
    Neonatology. 2022 Nov 28:1-8. doi: 10.1159/000527407.
    PubMed         Abstract available

    PLoS One

  29. KRONBERGER C, Mousavi RA, Ozturk B, Willixhofer R, et al
    Functional capacity testing in patients with pulmonary hypertension (PH) using the one-minute sit-to-stand test (1-min STST).
    PLoS One. 2023;18:e0282697.
    PubMed         Abstract available

    Pulm Circ

  30. CROSSMAN LM, Rajaram P, Hart CM, Pernetz MA, et al
    Evaluation of right ventricular strain in two separate cohorts with precapillary pulmonary hypertension.
    Pulm Circ. 2023;13:e12204.
    PubMed         Abstract available

  31. PHILIP N, Pi H, Gadkari M, Yun X, et al
    Transpulmonary amino acid metabolism in the sugen hypoxia model of pulmonary hypertension.
    Pulm Circ. 2023;13:e12205.
    PubMed         Abstract available

    Rheumatology (Oxford)

  32. KUTLUG AGACKIRAN S, Sunbul M, Dogan Z, Kocakaya D, et al
    Pulmonary arterial wall thickness increased in Behcet's disease patients with major organ involvement: Is it a sign of severity?
    Rheumatology (Oxford). 2023;62:1238-1242.
    PubMed         Abstract available

    Sci Rep

  33. MAMALAKIS M, Dwivedi K, Sharkey M, Alabed S, et al
    A transparent artificial intelligence framework to assess lung disease in pulmonary hypertension.
    Sci Rep. 2023;13:3812.
    PubMed         Abstract available

  34. ISHII S, Minatsuki S, Hatano M, Saito A, et al
    The ratio of TAPSE to PASP predicts prognosis in lung transplant candidates with pulmonary arterial hypertension.
    Sci Rep. 2023;13:3758.
    PubMed         Abstract available

    Sleep Breath

  35. XU Y, Hu T, Ding H, Yuan Y, et al
    miR-485-5p alleviates obstructive sleep apnea syndrome with hypertension by inhibiting PI3K/AKT signaling pathway via downregulating HIF3A expression.
    Sleep Breath. 2023;27:109-119.
    PubMed         Abstract available

    Ugeskr Laeger

  36. TINNING FB, Petersen OBB, Steensberg JN, Buchvald FF, et al
    [Diagnosis and treatment of a multisystemic disorder in children called congenital portosystemic shunts].
    Ugeskr Laeger. 2021;183:V01210041.
    PubMed         Abstract available

    Value Health Reg Issues

  37. EKHLASI M, Sheikhi S, Majd ZK, Peiravian F, et al
    Cost-Effectiveness Analysis of Macitentan in Comparison With Bosentan in the Treatment of Pulmonary Arterial Hypertension in Iran.
    Value Health Reg Issues. 2023;34:78-85.
    PubMed         Abstract available

    Vasc Health Risk Manag

  38. SWISHER JW, Weaver E
    The Evolving Management and Treatment Options for Patients with Pulmonary Hypertension: Current Evidence and Challenges.
    Vasc Health Risk Manag. 2023;19:103-126.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.